Drug firm blames price cuts for unit sale

20th September, 2015

The drug distribution group UDG has blamed significant drug price cuts demanded by the HSE and the North’s National Health Service as one of its reasons for selling off its wholesale division for more than €400 million last week.

Speaking to The Sunday Business Post, the UDG chief executive Liam Fitzgerald said price cuts have averaged 4 to 5 per cent per year even though the company was delivering the same, if not...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The twelve deals of the year

Alphabet soup: 2021 in review

EY reports €393m revenues in Republic of Ireland for 2021 financial year